(STUDY CLOSED) Phase 2 Study of Denosumab (IND#127430, NSC# 744010), a RANK Ligand Antibody, for Recurrent or Refractory Osteosarcoma

General Information

Age Group

Pediatrics/Children

Status

Inactive

Protocol Number

AOST1321

Offered At

Inova Children's Hospital
3300 Gallows Road
Falls Church, VA 22042